The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia.
Nemeroff
C B
CB
D000367:Age Factors; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry; D002490:Central Nervous System / Q000502:physiology*; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000502:physiology*; D006651:Histocytochemistry; D006801:Humans; D007120:Immunochemistry; D007276:Injections, Intraventricular; D008032:Limbic System / Q000378:metabolism / Q000502:physiology; D051379:Mice; D009496:Neurotensin / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology; D009638:Norepinephrine / Q000502:physiology*; D051381:Rats; D012559:Schizophrenia / Q000188:drug therapy / Q000209:etiology*; D013378:Substantia Nigra / Q000378:metabolism; D009435:Synaptic Transmission
D014150:Antipsychotic Agents; D009496:Neurotensin; D004298:Dopamine; D009638:Norepinephrine